Holding(s) in Company

RNS Number : 1395M

Shield Therapeutics PLC

09 January 2023

 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYV81293

Issuer Name

SHIELD THERAPEUTICS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights; An event changing the breakdown of voting rights

3. Details of person subject to the notification obligation

Name

Jupiter Fund Management PLC

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Name	City of registered office	Country of registered office
Northern Trust

5. Date on which the threshold was crossed or reached

06-Jan-2023

6. Date on which Issuer notified

09-Jan-2023

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	6.700000	0.000000	6.700000	37146992
Position of previous notification (if applicable)	4.680000	0.000000	4.680000

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB00BYV81293		37146992		6.700000
Sub Total 8.A	37146992		6.700000%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
Jupiter Fund Management Plc ( Chain 1)		0.000000	0.000000	0.000000%
Jupiter Fund Management Plc ( Chain 1)	Jupiter Fund Management Group Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc ( Chain 1)	Jupiter Asset Management Group Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc ( Chain 1)	Knightsbridge Asset Management Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc ( Chain 1)	Jupiter Investment Management Group Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc ( Chain 1)	Jupiter Asset Management Limited	6.700000	0.000000	6.700000%
Jupiter Fund Management Plc (Chain 2)	Merian Global Investors Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc (Chain 2)	Merian Global Investors (Jersey) Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc (Chain 2)	Merian Global Investors (Finance) Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc (Chain 2)	Merian Global Investors Holdings Limited	0.000000	0.000000	0.000000%
Jupiter Fund Management Plc (Chain 2)	Jupiter Investment Management Limited	0.000000	0.000000	0.000000%

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

12. Date of Completion

09.01.2023

13. Place Of Completion

London, UK

 

END

 

 

HOLBLMATMTTMBMJ